Interpretable prediction of Ki-67 expression in breast cancer through integrated photoacoustic radiomics and clinical parameters
Frontiers in Oncology · 29.04.2026 · 16
DOI: 10.3389/fonc.2026.1832391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 29.04.2026. Verfasst von Mengyun Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
This study aimed to develop a noninvasive method for preoperatively predicting Ki-67 expression in breast cancer (BC) by integrating radiomics features derived from photoacoustic/ultrasound (PA/US) imaging with clinical factors. Materials and methods A total of 223 patients with pathologically confirmed BC underwent PA/US imaging before surgery. Radiomics features were extracted from tumor regions, standardized, and selected using statistical testing, correlation analysis, and least absolute shrinkage and selection operator (LASSO) regression. Ten machine learning algorithms were compared, and the best-performing classifier was used to construct the radiomics model. Clinical variables significantly associated with Ki-67 expression were then incorporated to build a combined model. Model performance was evaluated using receiver operating characteristic (ROC) curve analysis, calibration analysis, and decision curve analysis.
Results
In the test set, the clinical, radiomics, and combined models achieved areas under the ROC curve (AUCs) of 0.722, 0.826, and 0.849, respectively. The combined model also demonstrated higher sensitivity (0.957) and negative predictive value (0.867), indicating strong capability in identifying patients with high Ki-67 expression. SHAP analysis confirmed that texture- and intensity-related imaging features played important roles in model prediction.
Conclusion
PA/US-based radiomics provides a quantitative, interpretable, and clinically valuable approach for assessing tumor proliferation in BC. The combined model exhibited superior accuracy over single-modality models and shows promise as an effective supplementary tool for individualized preoperative evaluation of Ki-67 expression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, China.
- Department of Medical Ultrasound, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Ultrasound, Rizhao People's Hospital, Rizhao, China.
Zitieren
APA
Wang, M., Mo, S., Shi, H., Huang, Z., Li, G., Li, J., Liu, Q., Xu, J., & Dong, F. (2026). Interpretable prediction of Ki-67 expression in breast cancer through integrated photoacoustic radiomics and clinical parameters. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1832391
Vancouver
Wang M, Mo S, Shi H, Huang Z, Li G, Li J, et al. Interpretable prediction of Ki-67 expression in breast cancer through integrated photoacoustic radiomics and clinical parameters. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1832391
BibTeX
@article{Wang2026,
author = {Wang, Mengyun and Mo, Sijie and Shi, Hui and Huang, Zhibin and Li, Guoqiu and Li, Jingjing and Liu, Qinghua and Xu, Jinfeng and Dong, Fajin},
title = {Interpretable prediction of Ki-67 expression in breast cancer through integrated photoacoustic radiomics and clinical parameters},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1832391}
}
EUVIMED